Identification of a secondary binding site in human macrophage galactose-type lectin by microarray studies: Implications for the molecular recognition of its ligands.


Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
25 01 2019
Historique:
received: 19 07 2018
revised: 26 11 2018
pubmed: 7 12 2018
medline: 30 4 2019
entrez: 4 12 2018
Statut: ppublish

Résumé

The human macrophage galactose-type lectin (MGL) is a C-type lectin characterized by a unique specificity for terminal GalNAc residues present in the tumor-associated Tn antigen (αGalNAc-Ser/Thr) and its sialylated form, the sialyl-Tn antigen. However, human MGL has multiple splice variants, and whether these variants have distinct ligand-binding properties is unknown. Here, using glycan microarrays, we compared the binding properties of the short MGL 6C (MGL

Identifiants

pubmed: 30504228
pii: S0021-9258(20)38867-0
doi: 10.1074/jbc.RA118.004957
pmc: PMC6349122
pii:
doi:

Substances chimiques

Epitopes 0
Glycopeptides 0
Lectins, C-Type 0
Ligands 0
MGL lectin, human 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1300-1311

Subventions

Organisme : NIGMS NIH HHS
ID : P41 GM103390
Pays : United States
Organisme : NIGMS NIH HHS
ID : U54 GM062116
Pays : United States

Informations de copyright

© 2019 Marcelo et al.

Références

Glycobiology. 2014 May;24(5):402-6
pubmed: 24653214
Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10056-61
pubmed: 20479270
Glycobiology. 2002 Dec;12(12):851-6
pubmed: 12499407
J Biol Chem. 1996 Mar 22;271(12):6679-85
pubmed: 8636086
Bioinformatics. 2014 Dec 1;30(23):3417-8
pubmed: 25143288
J Proteome Res. 2008 Apr;7(4):1650-9
pubmed: 18311910
Chem Soc Rev. 2017 Nov 27;46(23):7154-7175
pubmed: 29022615
ACS Chem Biol. 2017 Aug 18;12(8):2172-2182
pubmed: 28644609
J Am Chem Soc. 2007 Aug 1;129(30):9458-67
pubmed: 17616194
Curr Opin Struct Biol. 2015 Oct;34:26-34
pubmed: 26163333
J Biol Chem. 2002 Jun 7;277(23):20686-93
pubmed: 11919201
J Exp Med. 2012 Jan 16;209(1):109-21
pubmed: 22213806
Blood. 2010 Nov 4;116(18):3526-36
pubmed: 20720186
Chemistry. 2014 Dec 1;20(49):16147-55
pubmed: 25324212
J Biol Chem. 2013 Sep 20;288(38):27519-32
pubmed: 23918927
Glycobiology. 2010 Mar;20(3):270-9
pubmed: 19939826
FEBS J. 2005 Dec;272(24):6179-217
pubmed: 16336259
Cancer Res. 2007 Sep 1;67(17):8358-67
pubmed: 17804752
Mol Immunol. 2009 Mar;46(6):1240-9
pubmed: 19162326
Oncotarget. 2015 Sep 22;6(28):26278-90
pubmed: 26172302
ACS Chem Biol. 2012 Jun 15;7(6):1031-9
pubmed: 22444368
Glycobiology. 2017 Jul 1;27(7):677-687
pubmed: 28025250
J Am Chem Soc. 2006 Nov 15;128(45):14640-8
pubmed: 17090050
PLoS One. 2015 May 07;10(5):e0125994
pubmed: 25951175
Proc Natl Acad Sci U S A. 1977 Jul;74(7):3023-7
pubmed: 268649
J Am Chem Soc. 2016 Apr 13;138(14):4787-95
pubmed: 27010847
Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16613-8
pubmed: 12464682
ACS Chem Biol. 2015 Mar 20;10(3):747-56
pubmed: 25457745
Int Immunol. 2005 May;17(5):661-9
pubmed: 15802303
Cell. 1991 Dec 20;67(6):1103-10
pubmed: 1662117
Nat Rev Immunol. 2018 Mar;18(3):204-211
pubmed: 29398707
Carbohydr Res. 2005 Sep 26;340(13):2111-22
pubmed: 16026772
Glycobiology. 2013 Jul;23(7):853-64
pubmed: 23507965
J Immunol. 1996 Jan 1;156(1):128-35
pubmed: 8598452
Oncotarget. 2014 Jun 15;5(11):3673-84
pubmed: 25003232
J Biol Chem. 1995 Oct 13;270(41):24116-26
pubmed: 7592613
Cancer Immunol Immunother. 2007 Aug;56(8):1225-36
pubmed: 17195076
Proteins. 2006 Nov 15;65(3):712-25
pubmed: 16981200
Nat Immunol. 2006 Nov;7(11):1200-8
pubmed: 16998493
Biomed Res Int. 2014;2014:981627
pubmed: 25003135
Blood. 2018 Feb 22;131(8):911-916
pubmed: 29282218
OMICS. 2014 Apr;18(4):231-41
pubmed: 24502776
J Am Chem Soc. 2018 Aug 8;140(31):9952-9960
pubmed: 30004703
Glycobiology. 2013 Jul;23(7):844-52
pubmed: 23507963
J Biol Chem. 2008 Nov 28;283(48):33665-73
pubmed: 18790731
J Mol Biol. 2009 Dec 11;394(4):613-20
pubmed: 19835887
J Med Chem. 2017 Nov 9;60(21):9012-9021
pubmed: 29045792
J Comput Chem. 2008 Mar;29(4):622-55
pubmed: 17849372
J Biol Chem. 2002 Aug 9;277(32):28892-901
pubmed: 12016228
J Biol Chem. 1999 Apr 16;274(16):10697-705
pubmed: 10196140
Immunobiology. 2006;211(6-8):577-85
pubmed: 16920496
Chemistry. 2014 Sep 22;20(39):12616-27
pubmed: 25111627

Auteurs

Filipa Marcelo (F)

Departamento de Química, Faculdade de Ciências e Tecnologia, UCIBIO, REQUIMTE, 2829-516 Caparica, Portugal.

Nitin Supekar (N)

Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia 30602.

Francisco Corzana (F)

Departamento de Química, Universidad de La Rioja, Centro de Investigación en Síntesis Química, E-26006 Logroño, Spain.

Joost C van der Horst (JC)

Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HZ Amsterdam, The Netherlands.

Ilona M Vuist (IM)

Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HZ Amsterdam, The Netherlands.

David Live (D)

Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia 30602.

Geert-Jan P H Boons (GPH)

Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia 30602.

David F Smith (DF)

Department of Biochemistry, Emory Comprehensive Glycomics Center, Emory University School of Medicine, Atlanta, Georgia 30322.

Sandra J van Vliet (SJ)

Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HZ Amsterdam, The Netherlands. Electronic address: s.vanvliet@vumc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH